K

Kotak Healthcare Fund - Direct Plan - Growth Option

Kotak Mahindra Asset Management Company Limited.

NAV

₹18.847

NAV as of 13 Nov 2026

+0.0810 (+0.4316%)
Returns, 3Y

—

Annualised return

AUM (FUND SIZE)

₹682 Cr

Assets Under Mgmt

SINCE INCEPTION

+24.21%

Launched 18 Dec 2023

₹1 SINCE LAUNCH

₹1.88

Indexed wealth

MAX DRAWDOWN

-18.05%

Historical peak to trough

RECOVERY TIME

14 mo

To previous peak

CONSISTENCY

2 positive yrs

1 negative yrs

Category

EquitySectoral/ ThematicVery High Risk

Fund Info

INF174KA1PZ7Kotak Mahindra Asset Management Company Limited.
+34.26%1Y Absolute Return
+0.43%1D
Loading NAV history…

Past performance is not an indicator of future returns.

Returns calculator comparison

Compare an illustrative investment outcome across return assumptions.

AssetProjected corpusTotal investedGainAnnual return
Kotak Healthcare Fund - Direct Plan - Growth OptionFund 1Y annualised return · 5Y history unavailable
₹18,24,229
₹7,32,612₹10,91,617+34.26%
EPFIllustrative annual assumption
₹8,95,132
₹7,32,612₹1,62,520+8.25%
Residential propertyIllustrative annual assumption
₹8,67,662
₹7,32,612₹1,35,050+7.00%
PPFIllustrative annual assumption
₹8,69,819
₹7,32,612₹1,37,207+7.10%
Bank fixed depositIllustrative annual assumption
₹8,56,981
₹7,32,612₹1,24,369+6.50%
GoldIllustrative annual assumption
₹8,67,662
₹7,32,612₹1,35,050+7.00%
Savings accountIllustrative annual assumption
₹7,86,827
₹7,32,612₹54,215+3.00%

Illustration only. Fund results use the available NAV-derived annualised return and can be negative. Reference rows are assumptions, not current quoted rates or guaranteed returns; property excludes transaction costs, taxes, and liquidity constraints. Mutual fund investments are subject to market risk.

Wealth multiple

₹1 became₹1.24
₹1 Lakh since launch₹1.24 Lakh
Fund age2.9 yrs

Fund information

Scheme code152214
ISININF174KA1PZ7
BenchmarkNIFTY Healthcare TRI.
CategoryEquity Scheme - Sectoral/ Thematic
Expense ratio1.07%
Exit load0.5% for redemption within 30 Days
Minimum SIP₹100 SIP

Return comparison

6th / 932 in category
PeriodFundBenchmarkCategory avg
1M+250.79%——
3M+37.58%——
6M+48.57%——
1Y+34.26%—+4.16%
Since Launch+24.21%——

Risk-adjusted performance

Every measure is expanded with a plain-language reading of the latest calculated value.

Sharpe ratio

1.14

Return earned for the risk taken.

Good

Good risk-adjusted returns. The fund has delivered strong returns for its level of risk.

Sortino ratio

1.66

Return earned while limiting downside risk.

Good

Good downside protection with strong returns.

Standard deviation

14.69%

How much the fund’s returns fluctuate over time.

Moderate volatility

Returns can move up and down noticeably.

Beta

—

How closely the fund moves with the market.

Unavailable

This measure needs sufficient fund and benchmark history to calculate.

Alpha

—

Extra return generated above the benchmark.

Unavailable

This measure needs sufficient fund and benchmark history to calculate.

Treynor ratio

—

Return earned for each unit of market risk taken.

Unavailable

This measure needs sufficient fund and benchmark history to calculate.

Calmar ratio

1.34

How well the fund rewarded investors relative to its biggest decline.

Excellent

Excellent balance between returns and drawdowns.

Information ratio

—

How consistently the fund outperformed its benchmark.

Unavailable

This measure needs sufficient fund and benchmark history to calculate.

Portfolio allocation

Latest disclosed portfolio mix

Asset allocation

Allocation data has not been disclosed.

Market cap allocation

Small Cap
54.72%
Large Cap
22.79%
Unclassified
4.32%
Mid Cap
16.90%

Sector allocation

Equity exposure by sector

Healthcare
96.90%
Materials
1.83%

Top holdings

10 of 34 disclosed positions

HoldingSectorInstrument typeWeight
Sun Pharmaceutical Industries LtdHealthcareEquity14.88%
Divi's Laboratories LtdHealthcareEquity8.26%
Torrent Pharmaceuticals LtdHealthcareEquity6.16%
Max Healthcare Institute LtdHealthcareEquity5.15%
Cipla LtdHealthcareEquity4.32%
Ami Organics LtdHealthcareEquity4.32%
Park Medi World Ltd.HealthcareEquity3.86%
Fortis Healthcare LtdHealthcareEquity3.46%
Mankind Pharma Ltd.HealthcareEquity3.26%
Sai Life Sciences Ltd.HealthcareEquity3.08%

Fund management

DH
Dhananjay Tikariha

Since 2023 · Prior to joining Kotak Mahindra Mutual Fund, he has worked with IDFC First Bank

Mr. Tikariha has done B.Tech, M. Tech from IIT Madras and PGDM (Finance & Marketing) from IIM Lucknow

AB
Abhishek Bisen

Since 2023 · Prior to joining Kotak AMC, he was working with Securities Trading Corporation Of India Ltd where he was looking at Sales & Trading of Fixed Income Products apart from doing Portfolio Advisory. His earlier assignments also include 2 years of merchant banking experience with a leading merchant banking firm.

Mr. Bisen is a BA and MBA in Finance.

Compare similar funds

No comparable category funds are available yet.
Summary

A very high-risk equity scheme - sectoral/ thematic fund. Losses and swings stayed contained — worst fall -18.1%, volatility 14.7%. Healthcare makes up 97% — trouble in that sector hits the whole fund.

Strengths
  • Losses and swings stayed contained — worst fall -18.1%, volatility 14.7%.
  • Ranks 6 of 932 in its category over 1 year.
Weaknesses
  • None
Ideal investor
  • Needs a 5–7+ years horizon to ride out its very high risk level.
  • Good fit for SIPs — spreading purchases smooths out 14.7% volatility.
Risk drivers
  • Healthcare makes up 97% — trouble in that sector hits the whole fund.